Trials / Completed
CompletedNCT00136331
Study of a Pandemic Influenza Vaccine
Phase Ia Study of a Pandemic Influenza Vaccine
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 400 (planned)
- Sponsor
- Seqirus · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The World Health Organisation has warned that an influenza pandemic is inevitable. The avian influenza H5N1 virus strain is the leading candidate to cause the next avian influenza pandemic. This study will test the safety and immunogenicity of a H5N1 pandemic influenza vaccine in healthy adults.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Pandemic influenza vaccine |
Timeline
- Start date
- 2005-10-01
- Completion
- 2006-11-01
- First posted
- 2005-08-29
- Last updated
- 2016-07-19
Locations
2 sites across 1 country: Australia
Source: ClinicalTrials.gov record NCT00136331. Inclusion in this directory is not an endorsement.